LivaNova
LIVN
251 hedge funds and large institutions have $3.97B invested in LivaNova in 2018 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 87 increasing their positions, 99 reducing their positions, and 48 closing their positions.
111% more call options, than puts
Call options by funds: $34.7M | Put options by funds: $16.4M
0.83% more ownership
Funds ownership: 88.2% → 89.03% (+0.83%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less funds holding
Funds holding: 271 → 251 (-20)
12% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 99
25% less capital invested
Capital invested by funds: $5.31B → $3.97B (-$1.34B)
38% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 48
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$113M |
| 2 |
HM
HealthCor Management
New York
|
+$88.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$79.7M |
| 4 |
Goldman Sachs
New York
|
+$36.4M |
| 5 |
JP Morgan Chase
New York
|
+$30.5M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$71.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$56.2M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$48.3M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$34.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$26.4M |
LIVN Hedge Fund Activity: Q4 2018 in Review
251 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q4 2018, worth a combined $3.97B — down 25% from $5.31B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of LIVN and 30 opened new positions — a net loss of 18 holders — while 99 trimmed existing stakes and 87 added.
The largest buyer was Morgan Stanley, adding an estimated $113M. The largest seller was Ameriprise, cutting an estimated $71.6M.
- 251 institutional investors held LivaNova (LIVN) as of Q4 2018, down from 271 in Q3 2018.
- Funds reported $3.97B of LivaNova stock for Q4 2018, down 25% quarter-over-quarter.
- 30 funds opened new LivaNova positions in Q4 2018 and 48 closed out, a net change of -18 holders.
- The largest LivaNova buyer in Q4 2018 was Morgan Stanley, an estimated $113M added.
- The largest LivaNova seller in Q4 2018 was Ameriprise, an estimated $71.6M sold.
Based on aggregated 13F filings for Q4 2018.